12 June 1998
Organ and Tissue Donation: Are Minorities Willing to Donate?
Dennis E Daniels, Karen Smith, Tereasa Parks-Thomas, Debbie Gibbs, Jade RobinsonAnn Transplant 1998; 3(2): 22-24 :: ID: 497380
Abstract
The largest minority group in the United States is the African American population, representing about 12 percent of the national population (Dept. of Health and Human Services [DHHS], 1985)Yet, this population represents more than thirty percent of the end stage renal disease patients (Lowrie& Hampers, 1981; Eggers et ai., 1984; Williams,1988). In 1988, the percentage of African Americans suffering from end stage renal disease had risen to 35.2%. At the end of 1995, of the 31149 persons awaking a renal transplant, 10808 (35.1%) were African American, 2845 (9.2%) Hispanic and 1127 (3.7%) Asian (OPTN/SR, 1996).
Keywords: Organ Donation, race, religions
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






